Back to Use Cases
Use Cases
16 min read

Synthetic Data in Healthcare: Advancing Research While Protecting Patient Privacy

Explore how synthetic patient data is enabling medical research, AI development, and clinical trials while maintaining HIPAA compliance.

Synthetic Data in Healthcare: Advancing Research While Protecting Patient Privacy

The Privacy Challenge in Healthcare Data

Healthcare data is among the most valuable for research and innovation, but also among the most sensitive and heavily regulated. Patient records contain a wealth of information that could drive medical breakthroughs, but privacy regulations like HIPAA in the US and GDPR in Europe strictly limit how this data can be shared and used.

Synthetic healthcare data offers a promising solution to this dilemma, enabling researchers and developers to work with realistic medical data without exposing actual patient information.

Applications in Healthcare

Medical Research

Synthetic patient data is enabling researchers to:

  • Share datasets across institutions without privacy concerns
  • Increase sample sizes for rare conditions
  • Test hypotheses before conducting expensive clinical studies
  • Develop and validate new analytical methods

For example, researchers at a major university used synthetic electronic health records to develop new algorithms for predicting disease progression, then validated these algorithms on real data in a secure environment.

AI and Machine Learning Development

Healthcare AI development faces significant data access challenges. Synthetic data helps by:

  • Providing training data for machine learning models
  • Creating balanced datasets with sufficient examples of rare conditions
  • Enabling development of algorithms for underrepresented populations
  • Allowing external vendors to develop solutions without accessing real patient data

A startup developing AI for radiology was able to train their initial models on synthetic imaging data before partnering with hospitals for validation, accelerating their development timeline by months.

Clinical Trial Design and Simulation

Synthetic data is transforming clinical trial processes by:

  • Simulating trial outcomes to optimize study design
  • Creating synthetic control arms to reduce the need for placebo groups
  • Modeling patient recruitment to identify potential challenges
  • Testing statistical analysis plans before trial completion

A pharmaceutical company used synthetic patient data to simulate various trial designs for a new therapy, identifying the most efficient approach before investing in the actual trial.

Medical Education and Training

Synthetic patient cases provide valuable educational resources:

  • Creating diverse case studies for medical students
  • Developing simulation scenarios for clinical training
  • Testing clinical decision support systems
  • Training healthcare professionals on rare conditions

Types of Synthetic Healthcare Data

Electronic Health Records (EHRs)

Synthetic EHR data replicates the complex structure of medical records, including:

  • Patient demographics
  • Diagnoses and problem lists
  • Medication histories
  • Laboratory results
  • Vital signs and observations
  • Clinical notes and reports

The challenge lies in maintaining realistic relationships between these elements, such as ensuring that medications align with diagnoses and lab values reflect underlying conditions.

Medical Imaging

Synthetic medical images can be generated for various modalities:

  • X-rays
  • CT scans
  • MRI
  • Ultrasound
  • Pathology slides

Advanced generative models can create images showing specific pathologies, varying degrees of disease progression, and diverse patient characteristics.

Genomic Data

Synthetic genomic data is particularly valuable given the highly identifiable nature of real genomic information. It can represent:

  • Genetic variations
  • Gene expression patterns
  • Genetic associations with diseases
  • Population-level genetic diversity

Generation Techniques

Statistical Approaches

Early methods used statistical modeling to generate synthetic healthcare data, capturing distributions and correlations in the original data. While relatively simple, these approaches may miss complex relationships.

Deep Learning Methods

Modern approaches leverage deep learning to capture intricate patterns:

  • GANs: Particularly effective for medical imaging and time-series data like ECGs
  • VAEs: Useful for structured EHR data with clear relationships
  • Transformer Models: Excellent for generating realistic clinical narratives and notes
  • Diffusion Models: Showing promise for high-resolution medical imaging

Hybrid Approaches

Many successful synthetic healthcare data solutions combine multiple techniques:

  • Using rule-based systems to ensure medical consistency
  • Incorporating domain knowledge through expert-defined constraints
  • Combining statistical methods with deep learning
  • Using differential privacy to provide formal privacy guarantees

Validation and Quality Assurance

Validating synthetic healthcare data requires specialized approaches:

  • Clinical Plausibility: Having medical experts review synthetic cases
  • Statistical Fidelity: Comparing distributions and relationships to real data
  • Utility Testing: Verifying that analyses yield similar conclusions to real data
  • Privacy Assessment: Ensuring no re-identification risk or memorization of real patients

Regulatory Considerations

While synthetic data can help with regulatory compliance, important considerations remain:

  • Synthetic data generation processes may still require IRB approval if they use real patient data
  • The level of privacy protection should be formally evaluated and documented
  • Transparency about the use of synthetic data in research publications and regulatory submissions is essential
  • Some applications may require validation against real data before clinical implementation

Case Study: COVID-19 Research

During the COVID-19 pandemic, synthetic patient data played a crucial role:

  • Enabling rapid sharing of COVID-19 case information across institutions
  • Facilitating development of early predictive models before large datasets were available
  • Supporting vaccine trial design and analysis
  • Allowing international collaboration while complying with varying privacy regulations

Future Directions

The future of synthetic healthcare data looks promising:

  • Increasingly realistic synthetic data across all healthcare modalities
  • Greater regulatory acceptance and formal frameworks for validation
  • Synthetic data marketplaces specific to healthcare
  • Integration with federated learning approaches
  • Patient-controlled synthetic data generation from personal health records

Conclusion

Synthetic healthcare data represents a transformative approach to the longstanding tension between data access and privacy in medical research and innovation. As generation techniques continue to improve and validation methods become more robust, synthetic data will likely become a standard tool in healthcare research, AI development, and clinical practice improvement.

Herman Mostein

Herman Mostein

CTO & Co-Founder

PhD in Computer Science from MIT, specializing in generative models and synthetic data generation.